Enzyvant Therapeutics GmbH   Report issue

For profit
Founded: Cambridge MA United States (2016)
Status: Acquired by Sumitomo Dainippon (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree